Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma

Ophthalmology

Volumn 119, Issue 8, 2012, Pages 1590-1595

  Mouriaux, Frédéric ^a,b,c   Diorio, Caroline ^a,d   Bergeron, Dan ^a,b   Berchi, Célia ^e   Rousseau, Alain ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CHU CÔTE DE NACRE   (France)

^d Faculté de Mé Decine   (Canada)

^e CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION TEST; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84864428310     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.01.045     Document Type: Article

References (26)

1. C.M. Mooy, P.T. De Jong Prognostic parameters in uveal melanoma: a review Surv Ophthalmol 41 1996 215 228
2. Collaborative Ocular Melanoma Study Group Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report no. 26 Arch Ophthalmol 123 2005 1639 1643
3. E. Kujala, T. Makitie, T. Kivela Very long-term prognosis of patients with malignant uveal melanoma Invest Ophthalmol Vis Sci 44 2003 4651 4659
4. S. Bakalian, J.C. Marshall, P. Logan Molecular pathways mediating liver metastasis in patients with uveal melanoma Clin Cancer Res 14 2008 951 956
5. A.G. Scholes, B.E. Damato, J. Nunn Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival Invest Ophthalmol Vis Sci 44 2003 1008 1011
6. C.L. Shields, M. Furuta, A. Thangappan Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes Arch Ophthalmol 127 2009 989 998
7. S. Eskelin, S. Pyrhonen, M. Hahka-Kemppinen A prognostic model and staging for metastatic uveal melanoma Cancer 97 2003 465 475
8. T. Sato, A. Babazono, J.A. Shields Time to systemic metastases in patients with posterior uveal melanoma Cancer Invest 15 1997 98 105
9. B. Damato Developments in the management of uveal melanoma Clin Experiment Ophthalmol 32 2004 639 647
10. T. Kivela, S. Eskelin, E. Kujala Metastatic uveal melanoma Int Ophthalmol Clin 46 2006 133 149
11. D.S. Gombos, K.R. Van Quill, M. Uusitalo, J.M. O'Brien Geographic disparities in diagnostic screening for metastatic uveal melanoma Ophthalmology 111 2004 2254 2258
12. L. Desjardins, C. Levy-Gabriel, L. Lumbroso-Lerouic Prognostic factors for malignant uveal melanoma: retrospective study on 2,241 patients and recent contribution of monosomy-3 research [in French] J Fr Ophtalmol 29 2006 741 749
13. F. Mouriaux, S. Saule, L. Desjardins, F. Mascarelli Normal and malignant choroidal melanocytes: from cell to clinical approach [in French] J Fr Ophtalmol 28 2005 781 793
14. E.S. Gragoudas, K.M. Egan, J.M. Seddon Survival of patients with metastases from uveal melanoma Ophthalmology 98 1991 383 389
15. The Collaborative Ocular Melanoma Study Group M. Diener-West, S.M. Reynolds, D.J. Agugliaro Screening for metastasis from choroidal melanoma: report 23 J Clin Oncol 22 2004 2438 2444
16. Collaborative Ocular Melanoma Study Group, prepared by COMS Mortality Coding Committee C.S. Moy, D.M. Albert, M. Diener-West et al. Cause-specific mortality coding: methods in the Collaborative Ocular Melanoma Study COMS report no. 14 Control Clin Trials 22 2001 248 262
17. Collaborative Ocular Melanoma Study Group Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15 Arch Ophthalmol 119 2001 670 676
18. K. Hendler, J. Pe'er, I. Kaiserman Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2) Anticancer Res 31 2011 351 357
19. G.S. Missotten, C.M. Korse, C. Van Dehn S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening: a comparison with liver function tests Tumour Biol 28 2007 63 69
20. I. Kaiserman, R. Amer, J. Pe'er Liver function tests in metastatic uveal melanoma Am J Ophthalmol 137 2004 236 243
21. C. Hicks, A.J. Foss, J.L. Hungerford Predictive power of screening tests for metastasis in uveal melanoma Eye (Lond) 12 1998 945 948
22. L.A. Donoso, D. Berd, J.J. Augsburger Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan abnormalities Arch Ophthalmol 103 1985 796 798
23. N.T. Felberg, J.A. Shields, J. Maguire Gamma-glutamyl transpeptidase in the prognosis of patients with uveal malignant melanoma Am J Ophthalmol 9 1983 467 473
24. S. Eskelin, S. Pyrhonen, P. Summanen Screening for metastatic malignant melanoma of the uvea revisited Cancer 85 1999 1151 1159
25. J.J. Augsburger, Z.M. Correa, N. Trichopoulos Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival Am J Ophthalmol 152 2011 5 9
26. M.A. Tempero, R.J. Petersen, R.K. Zetterman Detection of metastatic liver disease: use of liver scans and biochemical liver tests JAMA 248 1982 1329 1332